 Matthew Jackman
Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Weight Gain | 15 | 2019 | 561 | 1.560 |
Why?
| | Energy Metabolism | 25 | 2024 | 935 | 1.350 |
Why?
| | Dietary Fats | 13 | 2018 | 308 | 1.260 |
Why?
| | Obesity | 23 | 2022 | 3118 | 1.240 |
Why?
| | Weight Loss | 11 | 2021 | 859 | 1.180 |
Why?
| | Adipocytes | 6 | 2025 | 223 | 0.900 |
Why?
| | Caloric Restriction | 4 | 2019 | 133 | 0.800 |
Why?
| | Adipose Tissue | 10 | 2022 | 645 | 0.620 |
Why?
| | Mitochondria, Muscle | 4 | 2019 | 120 | 0.580 |
Why?
| | Rats, Wistar | 12 | 2024 | 450 | 0.530 |
Why?
| | Physical Conditioning, Animal | 6 | 2025 | 242 | 0.530 |
Why?
| | Energy Intake | 13 | 2020 | 512 | 0.520 |
Why?
| | Diet, High-Fat | 9 | 2018 | 266 | 0.470 |
Why?
| | Diet, Fat-Restricted | 5 | 2013 | 79 | 0.460 |
Why?
| | Body Weight | 7 | 2024 | 972 | 0.450 |
Why?
| | Muscle, Skeletal | 13 | 2022 | 1791 | 0.420 |
Why?
| | Ovariectomy | 6 | 2025 | 166 | 0.410 |
Why?
| | Leptin | 3 | 2025 | 248 | 0.370 |
Why?
| | Diet, Reducing | 1 | 2011 | 91 | 0.330 |
Why?
| | Rats | 19 | 2024 | 5585 | 0.320 |
Why?
| | Lipid Metabolism | 7 | 2017 | 529 | 0.320 |
Why?
| | Fatty Liver | 5 | 2018 | 253 | 0.320 |
Why?
| | Lactation | 3 | 2018 | 193 | 0.290 |
Why?
| | Liver | 9 | 2024 | 1899 | 0.290 |
Why?
| | Genes, Mitochondrial | 1 | 2008 | 13 | 0.270 |
Why?
| | NADH Dehydrogenase | 1 | 2008 | 20 | 0.270 |
Why?
| | Animals | 38 | 2025 | 38097 | 0.270 |
Why?
| | Triglycerides | 6 | 2015 | 520 | 0.250 |
Why?
| | Fatty Acids | 4 | 2021 | 457 | 0.250 |
Why?
| | Intra-Abdominal Fat | 1 | 2008 | 101 | 0.250 |
Why?
| | Physical Exertion | 3 | 2011 | 205 | 0.250 |
Why?
| | Estradiol | 2 | 2024 | 515 | 0.240 |
Why?
| | Antibodies, Blocking | 1 | 2025 | 37 | 0.230 |
Why?
| | Antigens, Protozoan | 1 | 2025 | 32 | 0.230 |
Why?
| | Antibodies, Protozoan | 1 | 2025 | 41 | 0.230 |
Why?
| | Plasmodium falciparum | 1 | 2025 | 37 | 0.230 |
Why?
| | Malaria, Falciparum | 1 | 2025 | 32 | 0.230 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2025 | 41 | 0.220 |
Why?
| | Ovary | 3 | 2024 | 234 | 0.220 |
Why?
| | Lipoprotein Lipase | 2 | 2021 | 56 | 0.220 |
Why?
| | Polymorphism, Genetic | 1 | 2008 | 615 | 0.220 |
Why?
| | Menopause | 3 | 2019 | 326 | 0.220 |
Why?
| | Protozoan Proteins | 1 | 2025 | 90 | 0.220 |
Why?
| | Overweight | 2 | 2022 | 614 | 0.220 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2025 | 129 | 0.210 |
Why?
| | Milk | 3 | 2018 | 119 | 0.210 |
Why?
| | Subcutaneous Fat | 2 | 2015 | 79 | 0.210 |
Why?
| | Insulin Resistance | 3 | 2025 | 1244 | 0.210 |
Why?
| | Oxidative Phosphorylation | 3 | 2016 | 209 | 0.210 |
Why?
| | Hematopoietic Stem Cells | 2 | 2025 | 435 | 0.210 |
Why?
| | Adaptation, Physiological | 4 | 2015 | 560 | 0.210 |
Why?
| | Body Composition | 5 | 2024 | 693 | 0.190 |
Why?
| | Antibodies, Neutralizing | 1 | 2025 | 340 | 0.190 |
Why?
| | Fructokinases | 2 | 2013 | 42 | 0.190 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 266 | 0.180 |
Why?
| | Oxygen Consumption | 4 | 2019 | 719 | 0.180 |
Why?
| | Oxidation-Reduction | 6 | 2011 | 1068 | 0.170 |
Why?
| | Acetyl-CoA Carboxylase | 2 | 2014 | 32 | 0.170 |
Why?
| | Antibodies, Viral | 1 | 2025 | 674 | 0.170 |
Why?
| | Exercise | 4 | 2018 | 2205 | 0.170 |
Why?
| | Mitochondria | 5 | 2022 | 992 | 0.160 |
Why?
| | Motor Activity | 2 | 2019 | 718 | 0.160 |
Why?
| | alpha-Linolenic Acid | 1 | 2000 | 8 | 0.160 |
Why?
| | Stearic Acids | 1 | 2000 | 15 | 0.160 |
Why?
| | Homeostasis | 3 | 2015 | 644 | 0.160 |
Why?
| | Oleic Acid | 1 | 2000 | 40 | 0.160 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 655 | 0.160 |
Why?
| | Appetite | 1 | 2020 | 80 | 0.150 |
Why?
| | Muscle Fibers, Fast-Twitch | 2 | 2016 | 18 | 0.150 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 212 | 0.150 |
Why?
| | Fasting | 2 | 2000 | 279 | 0.150 |
Why?
| | Muscle Fibers, Slow-Twitch | 2 | 2016 | 24 | 0.150 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 18 | 0.150 |
Why?
| | Lipogenesis | 1 | 2019 | 62 | 0.150 |
Why?
| | Thermogenesis | 1 | 2019 | 45 | 0.140 |
Why?
| | Antibodies, Monoclonal | 1 | 2025 | 1505 | 0.140 |
Why?
| | Diet | 3 | 2018 | 1278 | 0.140 |
Why?
| | Mitochondria, Liver | 2 | 2013 | 70 | 0.140 |
Why?
| | Physical Endurance | 2 | 2016 | 279 | 0.130 |
Why?
| | Diglycerides | 1 | 2018 | 61 | 0.130 |
Why?
| | Eating | 1 | 2020 | 387 | 0.130 |
Why?
| | Cholesterol | 1 | 2019 | 408 | 0.130 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2017 | 47 | 0.130 |
Why?
| | Cold Temperature | 1 | 2019 | 206 | 0.130 |
Why?
| | Global Health | 1 | 2021 | 403 | 0.130 |
Why?
| | Adipogenesis | 1 | 2017 | 56 | 0.130 |
Why?
| | Sphingolipids | 1 | 2018 | 83 | 0.130 |
Why?
| | Postprandial Period | 2 | 2015 | 114 | 0.130 |
Why?
| | Mice | 13 | 2025 | 18355 | 0.130 |
Why?
| | Rats, Sprague-Dawley | 4 | 2010 | 2525 | 0.130 |
Why?
| | Recurrence | 4 | 2019 | 1139 | 0.120 |
Why?
| | Metabolic Diseases | 1 | 2018 | 114 | 0.120 |
Why?
| | Catecholamines | 1 | 1996 | 88 | 0.120 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2017 | 143 | 0.120 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 178 | 0.120 |
Why?
| | Caffeine | 1 | 1996 | 74 | 0.120 |
Why?
| | Bone Density | 1 | 2019 | 487 | 0.110 |
Why?
| | Female | 24 | 2025 | 79035 | 0.110 |
Why?
| | Lipectomy | 1 | 2015 | 9 | 0.110 |
Why?
| | Mental Health Services | 1 | 2021 | 475 | 0.110 |
Why?
| | Carbon Radioisotopes | 3 | 2006 | 29 | 0.110 |
Why?
| | Thigh | 1 | 2015 | 48 | 0.110 |
Why?
| | Insulin | 3 | 2022 | 2516 | 0.110 |
Why?
| | Central Nervous System Stimulants | 1 | 1996 | 185 | 0.110 |
Why?
| | Cryoelectron Microscopy | 2 | 2025 | 222 | 0.100 |
Why?
| | Male | 21 | 2021 | 73003 | 0.100 |
Why?
| | Hyperlipidemias | 1 | 2015 | 120 | 0.100 |
Why?
| | Breast Feeding | 1 | 2018 | 447 | 0.100 |
Why?
| | Glycogen | 2 | 2008 | 55 | 0.100 |
Why?
| | Transcription Factors | 3 | 2019 | 1736 | 0.100 |
Why?
| | Time Factors | 4 | 2019 | 7133 | 0.100 |
Why?
| | Sucrose | 1 | 2013 | 114 | 0.100 |
Why?
| | Physical Fitness | 1 | 2014 | 207 | 0.090 |
Why?
| | Hormones | 2 | 2010 | 135 | 0.090 |
Why?
| | Disease Models, Animal | 6 | 2019 | 4568 | 0.090 |
Why?
| | Exercise Tolerance | 1 | 2014 | 283 | 0.090 |
Why?
| | Mothers | 2 | 2018 | 765 | 0.090 |
Why?
| | Mice, Inbred C57BL | 6 | 2025 | 5992 | 0.090 |
Why?
| | Appetite Regulation | 1 | 2011 | 31 | 0.080 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2011 | 35 | 0.080 |
Why?
| | Glucose Transporter Type 1 | 1 | 2011 | 48 | 0.080 |
Why?
| | Blood Glucose | 2 | 2018 | 2344 | 0.080 |
Why?
| | Estrous Cycle | 1 | 2010 | 22 | 0.080 |
Why?
| | Models, Biological | 2 | 2016 | 1764 | 0.080 |
Why?
| | Metabolism | 1 | 2010 | 44 | 0.080 |
Why?
| | Citric Acid Cycle | 2 | 2003 | 58 | 0.080 |
Why?
| | Biopsy | 2 | 2018 | 1082 | 0.080 |
Why?
| | Membrane Proteins | 2 | 2013 | 1166 | 0.080 |
Why?
| | Neural Pathways | 1 | 2011 | 317 | 0.070 |
Why?
| | Dietary Carbohydrates | 2 | 2009 | 147 | 0.070 |
Why?
| | Cell Proliferation | 3 | 2017 | 2514 | 0.070 |
Why?
| | Sex Characteristics | 3 | 2018 | 789 | 0.070 |
Why?
| | Adiponectin | 2 | 2022 | 242 | 0.070 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2008 | 20 | 0.070 |
Why?
| | Estrogen Receptor alpha | 1 | 2009 | 151 | 0.070 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 361 | 0.070 |
Why?
| | Humans | 15 | 2025 | 145763 | 0.070 |
Why?
| | Basal Metabolism | 1 | 2008 | 59 | 0.070 |
Why?
| | Adiposity | 4 | 2015 | 532 | 0.070 |
Why?
| | Hyperplasia | 1 | 2008 | 177 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 175 | 0.060 |
Why?
| | Carbon Dioxide | 2 | 2006 | 227 | 0.060 |
Why?
| | Estrogens | 1 | 2009 | 367 | 0.060 |
Why?
| | Palmitates | 1 | 2006 | 21 | 0.060 |
Why?
| | Breeding | 1 | 2006 | 63 | 0.060 |
Why?
| | Pyruvic Acid | 2 | 2003 | 51 | 0.060 |
Why?
| | Malaria Vaccines | 1 | 2025 | 11 | 0.060 |
Why?
| | Intestinal Absorption | 1 | 2006 | 103 | 0.060 |
Why?
| | Cross Reactions | 1 | 2025 | 130 | 0.060 |
Why?
| | Down-Regulation | 1 | 2008 | 618 | 0.060 |
Why?
| | Photoperiod | 2 | 2019 | 55 | 0.050 |
Why?
| | Rabbits | 2 | 1996 | 653 | 0.050 |
Why?
| | Adult | 8 | 2022 | 40872 | 0.050 |
Why?
| | Enteral Nutrition | 1 | 2006 | 217 | 0.050 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 43 | 0.050 |
Why?
| | Phosphorylation | 1 | 2008 | 1708 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 264 | 0.050 |
Why?
| | Epitopes | 1 | 2025 | 473 | 0.050 |
Why?
| | Perilipin-2 | 2 | 2013 | 40 | 0.050 |
Why?
| | Mice, Inbred BALB C | 1 | 2025 | 1261 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2025 | 499 | 0.050 |
Why?
| | Indians, North American | 1 | 2008 | 598 | 0.050 |
Why?
| | Animals, Newborn | 2 | 2017 | 896 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 65 | 0.040 |
Why?
| | Fructose | 2 | 2013 | 132 | 0.040 |
Why?
| | Pregnancy | 4 | 2018 | 7215 | 0.040 |
Why?
| | In Vitro Techniques | 3 | 2003 | 1049 | 0.040 |
Why?
| | Calorimetry, Indirect | 2 | 2011 | 72 | 0.040 |
Why?
| | Digestive System | 1 | 2000 | 29 | 0.040 |
Why?
| | Exercise Test | 2 | 2009 | 630 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2019 | 2805 | 0.040 |
Why?
| | Betaine | 2 | 2013 | 67 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 17 | 0.040 |
Why?
| | Protein Binding | 1 | 2025 | 2240 | 0.040 |
Why?
| | Feeding Behavior | 2 | 2018 | 692 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 35 | 0.040 |
Why?
| | Adipose Tissue, Brown | 1 | 2019 | 60 | 0.040 |
Why?
| | Fever | 1 | 2000 | 319 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 267 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 442 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 163 | 0.030 |
Why?
| | Perilipin-1 | 1 | 2017 | 16 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 35 | 0.030 |
Why?
| | Models, Animal | 1 | 2019 | 392 | 0.030 |
Why?
| | Phenotype | 1 | 2006 | 3170 | 0.030 |
Why?
| | Adenosine Triphosphate | 2 | 2016 | 500 | 0.030 |
Why?
| | Cell Size | 1 | 2017 | 93 | 0.030 |
Why?
| | Transcriptome | 1 | 2024 | 1042 | 0.030 |
Why?
| | Glucose Clamp Technique | 1 | 2018 | 199 | 0.030 |
Why?
| | Nutritional Status | 1 | 2000 | 353 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 213 | 0.030 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 79 | 0.030 |
Why?
| | Temperature | 1 | 2000 | 633 | 0.030 |
Why?
| | Cohort Studies | 1 | 2008 | 6032 | 0.030 |
Why?
| | Running | 1 | 2019 | 233 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 361 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2009 | 2393 | 0.030 |
Why?
| | PPAR gamma | 1 | 2017 | 182 | 0.030 |
Why?
| | Phosphocreatine | 1 | 2016 | 44 | 0.030 |
Why?
| | Creatine Kinase | 1 | 2016 | 72 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2011 | 11793 | 0.030 |
Why?
| | Physical Conditioning, Human | 1 | 2016 | 38 | 0.030 |
Why?
| | Norepinephrine | 1 | 1996 | 201 | 0.030 |
Why?
| | Electron Transport | 1 | 1996 | 110 | 0.030 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2015 | 15 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2013 | 3130 | 0.030 |
Why?
| | Ethanol | 1 | 2000 | 631 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1359 | 0.030 |
Why?
| | Lactic Acid | 1 | 1996 | 295 | 0.030 |
Why?
| | Double-Blind Method | 2 | 1996 | 2064 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 321 | 0.030 |
Why?
| | Bicycling | 1 | 1995 | 117 | 0.030 |
Why?
| | Choline | 1 | 1995 | 138 | 0.030 |
Why?
| | Proteins | 2 | 2013 | 1023 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 39 | 0.020 |
Why?
| | Body Temperature | 1 | 1994 | 227 | 0.020 |
Why?
| | Cell Respiration | 1 | 2013 | 105 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2014 | 128 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1994 | 532 | 0.020 |
Why?
| | Meals | 1 | 2014 | 130 | 0.020 |
Why?
| | Circadian Rhythm | 2 | 2009 | 513 | 0.020 |
Why?
| | Middle Aged | 4 | 2018 | 36302 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1247 | 0.020 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2014 | 192 | 0.020 |
Why?
| | Fatigue | 1 | 1995 | 365 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2014 | 344 | 0.020 |
Why?
| | DNA Methylation | 1 | 2017 | 690 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2110 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1482 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 295 | 0.020 |
Why?
| | Immunoblotting | 1 | 2011 | 295 | 0.020 |
Why?
| | Calcium | 1 | 2016 | 1191 | 0.020 |
Why?
| | Methylnitrosourea | 1 | 2009 | 7 | 0.020 |
Why?
| | Thermodynamics | 2 | 2003 | 419 | 0.020 |
Why?
| | Alkylating Agents | 1 | 2009 | 24 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 680 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2009 | 207 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 513 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1300 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1043 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2009 | 440 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1723 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1454 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4151 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5922 | 0.010 |
Why?
| | Glucose | 1 | 2011 | 1048 | 0.010 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 59 | 0.010 |
Why?
| | Cell Line | 1 | 2011 | 2823 | 0.010 |
Why?
| | Rats, Zucker | 1 | 2005 | 32 | 0.010 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2005 | 55 | 0.010 |
Why?
| | Lipid Peroxidation | 1 | 2005 | 168 | 0.010 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2005 | 96 | 0.010 |
Why?
| | Methionine | 1 | 2005 | 161 | 0.010 |
Why?
| | Malates | 1 | 2003 | 8 | 0.010 |
Why?
| | Glutathione | 1 | 2005 | 370 | 0.010 |
Why?
| | Glycolysis | 1 | 2005 | 340 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3551 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2018 | 2602 | 0.010 |
Why?
| | Risk Factors | 1 | 2017 | 10917 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2005 | 627 | 0.010 |
Why?
| | Carbon | 1 | 2003 | 176 | 0.010 |
Why?
| | Reperfusion Injury | 1 | 2005 | 292 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2015 | 2977 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2601 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2865 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2883 | 0.010 |
Why?
| | Pyruvate Carboxylase | 1 | 2000 | 3 | 0.010 |
Why?
| | Fluorescence Polarization | 1 | 2000 | 24 | 0.010 |
Why?
| | Radioisotope Dilution Technique | 1 | 2000 | 14 | 0.010 |
Why?
| | Kinetics | 1 | 2003 | 1568 | 0.010 |
Why?
| | Intracellular Membranes | 1 | 2000 | 77 | 0.010 |
Why?
| | Hydrolysis | 1 | 2000 | 197 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2000 | 335 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 14251 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2000 | 843 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 1995 | 610 | 0.010 |
Why?
| | Administration, Oral | 1 | 1995 | 867 | 0.010 |
Why?
|
|
Jackman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|